2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Urinary Bladder Cancer: new trials by email Literature Review of Urinary Bladder Cancer trials Research Report on Urinary Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of NanoDoce® in Participants With Urothelial Carcinoma NanoDoce (direct injection), NanoDoce (intravesical instillation) - Visit 2 Instillation, Institutional Standard of Care - Bladder Cancer, Urothelial Carcinoma | Phase 1 / Phase 2 | Completed | NanOlogy, LLC | 36 | 2019-04-02 | 2023-08-14 |
| Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ Vicinium - Urinary Bladder Cancer, Bladder Cancer | Phase 2 | Completed | Sesen Bio, Inc. | 46 | 2007-03-01 | 2020-05-12 |
Urinary Bladder Neoplasms (2) · Carcinoma, Transitional Cell (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Urogenital Neoplasms (1) · Urologic Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Urinary Bladder Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Carcinoma (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Urogenital Neoplasms (1) · Urologic Neoplasms (1)
Administration, Intravesical (1) · Docetaxel (1) · Neoadjuvant Therapy (1) · VB4-845 (1)
NanOlogy, LLC (1) · Sesen Bio, Inc. (1)
United States (2) · Canada (1)
Donald Lamm, MD, FACS (1) · Wendy Chapman (1)